http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2331416-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8ee484f4ba9a0406b8927b5be6c4f2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 |
| filingDate | 2007-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f99e05e74eab6792b83e8ff9939c2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d82f9b0cf4e798907ff513c96a17780 |
| publicationDate | 2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2331416-C1 |
| titleOfInvention | Method for enhancement of thrombocyte antioxidant proofness in arterial hypertension cases with metabolic syndrome |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, particularly to haematology, cardiology, and endocrinology; it can be applied to enhancement of thrombocyte antioxidant proofness in arterial hypertension cases with metabolic syndrome. For this purpose individually chosen low energy diet and graduated exercise are included in therapy. Also drug preparations valsartan by 80 mg every morning and trimethazidin by 1 pill twice a day are administered. n EFFECT: elimination of hemostasis system complications in arterial hypertension cases with metabolic syndrome. n 3 tbl, 1 ex, 2 dwg |
| priorityDate | 2007-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.